|Articles|July 29, 2022
TrialCard Names Scott Dulitz Chief Executive Officer
Founded in 2000, TrialCard is a life sciences commercialization company that provides a comprehensive suite of solutions to over 400 pharma, biotech, and medtech companies.
Advertisement
TrialCard Incorporated, a full-service life sciences commercialization partner, today announced that Scott Dulitz has been promoted to Chief Executive Officer by the Company's Board of Directors. Mr. Dulitz, a twenty-year veteran of the pharma services industry, joined TrialCard in 2015 and most recently served as President and Chief Strategy Officer.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals
2
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
3
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals
4
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
5